HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.


Email Updates

Receive our lunchtime briefing straight to your inbox

More in this Section

Mum says autistic son now homeless in hospital, calls on HSE to provide solution

Roscommon woman wins €500,000 on scratch card just one month after winning €25,000

Skeletal remains found washed up on Co Clare shore

Witness heard child scream on night father and 3-year-old son drowned in Dublin tragedy


Today's Stories

House fire upgraded to murder investigation 30 years later

Ryanair faces flight chaos if pilots ‘work to rule’

Taoiseach to spend €160k on reports assessing Government’s public image

New canon for former Ballincollig Gun Store

Lifestyle

Golden oldies: Jane Fonda and Robert Redford reunite in Our Souls at Night

The A-listers of Zeminar equipping Generation Z with the tools to deal with life’s challenges

Decoding craftsmanship at Cork event

More From The Irish Examiner